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INTRODUCTION 
 
An estimated 1.8 million people in the United Kingdom have diabetes mellitus 
(DM), which reflects around 3% of the population (Watkins 2003). Statistics of 
the World Health Organisation suggest that there were around 171 million 
diabetic patients worldwide in 2000 (an estimated prevalence of 3%). It is 
predicted that this number will increase to around 366 million patients 
worldwide by the year 2030 (an estimated prevalence of 5.2%) (WHO 2004). 
These figures suggest that the number of diabetic patients (either diagnosed 
or undiagnosed) attending optometric practice is also likely to increase 
significantly over the next two decades. It has been well documented that 
fluctuations in refractive power often accompany changing blood glucose 
levels (Okamoto et al. 2000; Giusti 2003; Sonmez et al. 2005); however, the 
nature and the aetiology of refractive fluctuations in diabetes mellitus is poorly 
understood. The aim of this paper is to review the scientific literature relating 
to refractive error changes associated with diabetes and to discuss the 
implications of these changes for the optometrist.  
 
Multiple organs or organ systems are affected by the disease process of 
diabetes mellitus. Some effects are acute (e.g. ketoacidosis, hypoglycaemia), 
and other effects are more chronic, taking a minimum of five years to develop 
(e.g. retinopathy). The chronic effects of diabetes on the retina are well known 
and are seen by ophthalmoscopic inspection and fluorescein angiography. 
The effects of diabetes on the anterior segment of the eye are less well 
reported in the literature but the effects of diabetes on the cornea and 
crystalline lens are thought to play a key role in the refractive error changes 
sometimes associated with the disease.  
 
Investigators have observed both myopic (Giusti 2003) and hyperopic 
(Okamoto et al. 2000; Sonmez et al. 2005) refractive shifts in diabetic 
patients, which have been related to changing plasma glucose concentration. 
It would be helpful for the eye care practitioner to understand how blood 
glucose concentration could potentially affect the ocular parameters that 
contribute to the refractive power of the eye. If such relationships could be 
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established, then eye care practitioners would be better placed to advise 
patients on expected visual signs and symptoms during periods of altering 
diabetic metabolic control. 
 
In the first part of this review, the effects of diabetes on the ocular structures 
that contribute to refractive power will be described. The second part of the 
paper reviews the scientific literature relating to refractive power shifts in 
diabetes. The third part considers the main hypotheses as to how myopic and 
hypermetropic shifts could occur with changing blood glucose concentration. 
The final part of the paper considers the implications for the optometrist in 
practice. 
 
THE ANTERIOR OCULAR MANIFESTATIONS OF DIABETES  
 
Cornea 
Curvature and thickness 
The cornea contributes approximately two-thirds of the refractive power of the 
human eye. Variations in curvature of either the anterior or the posterior 
corneal surface or changes in corneal thickness can alter the corneal 
refractive power.  
 
Diabetes can lead to structural changes in corneal epithelial cells (Tsubota et 
al. 1991a; Tsubota et al. 1991b; Hosotani et al. 1995; McNamara et al. 1998) 
and endothelial cells (Schultz et al. 1984; Larsson et al. 1996). However, 
changes in central corneal curvature do not appear to be associated with 
altering blood glucose levels in diabetic patients (Saito et al. 1993; Okamoto 
et al. 2000). Saito et al (1993) and Okamoto et al (2000) investigated the 
degree of change in corneal curvature associated with the rapid correction of 
hyperglycemia. In a study of 28 eyes of 14 diabetic patients, Okamoto et al 
found no change in corneal curvature with changing blood glucose 
concentration. Saito et al investigated 10 eyes of 5 patients and came to 
similar conclusions.  
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Planten and co-workers carried out several studies to investigate the cause of 
refractive error changes in newly-diagnosed diabetic patients. Twenty-three 
patients had reported that they experienced fluctuations in their vision. The 
authors speculated that the refractive changes occurring in these patients was 
due to a change in the refractive index of the cornea or crystalline lens as 
previous studies had found no significant acute changes in lens curvature or 
position (Planten 1975; Planten et al. 1979; Planten 1981).    
 
In several studies of corneal thickness in Type I diabetic patients, corneal 
thickness was found to be increased compared to that of age-matched 
controls (Busted et al. 1981; Pierro et al. 1993; Weston et al. 1995; Larsson et 
al. 1996).  This is in contrast with the findings of other workers (Schultz et al. 
1984; McNamara et al. 1998). Generally researchers have failed to 
demonstrate significant differences in corneal thickness between Type II 
diabetic patients and age-matched control subjects (Schultz et al. 1984; 
Larsson et al. 1996).  
 
Refractive index and corneal endothelial cells 
In the human eye, the refractive index of the corneal epithelium is 1.401, the 
underlying stroma is approximately 1.38 and the corneal endothelium is 1.372 
(Patel et al. 1995). There are relatively few experimental measurements of 
human corneal refractive index described in the literature.  These values tend 
to be based on histological and mathematical data (Fatt and Harris 1973; 
Laing et al. 1976). Nevertheless, corneal refractive index may be an important 
parameter to consider in diabetes, since the influx of metabolites (including 
glucose) from the aqueous humour may change the corneal refractive index 
significantly and thus affect corneal refractive power. Using the formula: 
 
Fcornea = (ncornea –1) * rcornea -1; 
 
where Fcornea is corneal power, ncornea is corneal refractive index, and rcornea is 
the radius of curvature of the central cornea (Ellis et al.) and assuming 
Gullstrand constants, where ncornea = 1.376 and rcornea = 7.7mm: a change of 
approximately 0.0075 in refractive index will induce a 1 D change in corneal 
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power. Additionally, a change in central corneal curvature of 0.2mm would 
give a change of approximately 1 D in corneal power. 
 
Recent evidence linking elevated glucose concentration to reduced corneal 
endothelial Na+, K+-ATPase activity is of interest since this enzyme is an 
important component of the endothelial pump which is thought to be 
responsible for maintaining corneal hydration control (Whikehart et al. 1993). 
In light of this finding, it is perhaps not surprising that corneal thickness and 
time to recover from induced oedema are often increased in diabetic humans 
and animal models (Herse 1990a, 1990b). Oedema occurs when there is a 
significant reduction in the amount of oxygen reaching the cornea. The total 
corneal swelling induced by contact lens induced hypoxia has been shown to 
decrease with increasing blood glucose concentration in diabetic patients. 
(McNamara et al. 1998). 
 
 
Crystalline lens 
Thickness 
Lens thickness is often greater in diabetic patients than in non-diabetic 
subjects, mainly due to cortical thickening (Huggert 1953; Brown and 
Hungerford 1982). Other biometric changes include steepening of the anterior 
and posterior surfaces of the lens and shallowing of the anterior chamber 
(Sparrow et al. 1990). After adjusting for age, these changes are more 
pronounced in Type I diabetic patients and in patients with increased disease 
duration. Age-related increases in axial lens thickness, cortical thickness and 
nuclear thickness are accelerated after the onset of diabetes (Sparrow et al. 
1990). These findings could explain the increased prevalence of myopia found 
in diabetic patients. The expansion of the sagittal width of the lens is also 
accelerated in diabetic patients (Sparrow et al. 1990). Neither age nor disease 
duration appears to be responsible for these changes; however, the presence 
of diabetic retinopathy in Type 1 patients does seem to have an effect.  
 
In the crystalline lens, refractive index has been found to be highest at the 
centre and lowest at the periphery of the lens (Gullstrand 1909; Smith 2003). 
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It may be that small changes in refractive index in the centre of the lens could 
induce an acute shift in refractive error in diabetic patients. We would expect a 
3D change in refraction with a 0.02 change in refractive index (Planten 1981).  
 
The size of the expected change in the crystalline lens in diabetes mellitus 
can be calculated with the help of Le Grand’s theoretical eye (Wyszecki and 
Stiles 1982). To obtain a change in refraction of 2D with an anterior chamber 
depth of 3.1mm, the anterior surface of the lens would have to shift by 0.5mm, 
and change its radius from 10.2 to 14.1mm. Alternatively the entire lens would 
need to shift by approximately 1.5mm to obtain a 2D change in refraction. 
However, only a small change in refractive index (e.g. from 1.42 to 1.41) 
would be required for the same refractive change, making refractive error 
changes more likely to explain these shifts (Planten et al. 1979). 
 
Accommodation 
An aspect of ocular performance that seems to be affected in young diabetic 
patients is accommodation. The amplitude of accommodation in Type I 
patients is lower than that of age-matched control subjects (Moss et al. 1987; 
Mantyjarvi and Nousiainen 1988; Braun et al. 1995). It appears that even 
when there is no detectable retinal damage, the amplitude of accommodation 
in Type I patients is lower than that of age-matched healthy subjects. 
Furthermore, it appears that the latency of the response is unusually long 
(Braun et al. 1995).  
 
Cataract 
The intracellular accumulation of sorbitol (a by product of glucose metabolism) 
during poor metabolic control (hyperglycemia) will not only create an osmotic 
gradient leading to the uptake of water and lens swelling (Gabbay 1973), but 
will also cause a change in solubility (precipitation) of lens proteins which can 
lead to metabolic cataract formation (Kinoshita and Merola 1964; Caird et al. 
1969; Ehrlich et al. 1987).  
 
Cataract is more commonly found among diabetic patients, particularly in 
women and in patients with longer duration disease (Harding et al. 1993; 
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Rotimi et al. 2003; Hennis et al. 2004). Hypoglycemia induced by strict control 
of blood glucose in diabetic patients may induce cataract, since glucose is the 
major energy source of the lens (Vinding and Nielsen 1984). Cataract 
formation is associated with lens swelling, vacuole formation, and increased 
membrane permeability. Different forms of cataract in diabetic patients are 
juvenile cataract (opacity shaped like a snowflake, affecting the anterior and 
posterior cortical layer of the lens in young diabetics) (Nielsen and Vinding 
1984) and age-related cataract (nuclear, cortical, and posterior subcapsular) 
cataract (Leske et al. 1991).  Studies of young type I diabetic patients (with no 
detectable cataract on slit lamp) suggest that there is increased light scatter in 
diabetic patients that appears to correlate with HbA1c and the degree of 
diabetic retinopathy present (Kato et al. 2000; Kato et al. 2001).   
 
Aqueous humour  
Patients with type 1 diabetes have reduced aqueous flow rates (Hayashi et al. 
1989). This does not appear to occur in patients with type 2 diabetes (Larsson 
et al. 1995). One of the determinants of aqueous humour production is ocular 
blood flow (Bill 1975), which has been shown to increase with acute 
elevations in glucose concentration in type 1 diabetic patients (Bursell et al. 
1996). Therefore, an increase of blood flow might be expected to induce an 
increase in aqueous flow. Lane and co-workers studied aqueous flow, ocular 
blood flow, and intra-ocular pressure in type 1 diabetic patients and control 
subjects, controlling for glucose and insulin concentration (Lane et al. 2001). 
They found a decrease in aqueous flow in type I patients versus fasting 
controls; however, aqueous production did not appear to be affected by 
insulin or glucose concentrations. 
 
REFRACTIVE ERROR AND DIABETES 
 
Axial Length 
The results of a recent study suggested that axial length is reduced in diabetic 
patients compared with control subjects (Pierro et al. 1999). In this study axial 
length was negatively correlated with the degree of diabetic retinopathy (mean 
axial length was decreased in the subjects with background and proliferative 
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retinopathy compared to the group without retinopathy). No difference in axial 
length was found between the diabetic patients without retinopathy and the 
control subjects. Refractive power was not measured during this study. 
 
Refractive error 
Since the 19th century, it has been recognised that changes in blood glucose 
concentration can influence vision in patients with diabetes (Da Costa 1890; 
Duke-Elder 1925). Optometrists are trained to consider the possibility of 
undiagnosed diabetes if a patient complains of a bilateral, unexpected or rapid 
change of vision or prescription. If diabetes is suspected, the eye care 
practitioner may postpone prescribing spectacles until the refractive error has 
stabilised, which generally occurs when the patient’s diabetes is better 
controlled. Refractive changes associated with diabetes can be both acute 
(transient) and chronic (sustained). However, relatively little is known about 
the biochemical changes, which accompany these refractive events. 
 
Chronic refractive changes reported in diabetic patients include an increase in 
myopia (Fledelius 1983, 1986, 1987; Mantyjarvi 1988). These refractive 
changes tend to be of a low magnitude and present during adulthood. One 
author studied the frequency of myopia among 1,416 Danish adults (including 
381 adults with diabetes), and found a significantly higher prevalence of 
myopia among diabetic compared to non-diabetic subjects (38% in diabetic 
subjects versus 27.5% in non-diabetics) (Fledelius 1983). Myopia patterns 
(age of onset and degree) were investigated in another study, including 80 
diabetic and 80 non-diabetic, Danish, myopic adults. The author found that 
the mean refractive values of the two groups were –2.00D and –3.00D 
respectively, but late-onset myopia was more prevalent among diabetic 
patients (40.0% compared to 22.5% in non-diabetics). However, this study 
was based on self-reported data (Fledelius 1986). As stated above an 
increase in lens thickness (Brown and Hungerford 1982) or in surface 
curvature (Sparrow et al. 1990) could explain the increased prevalence of 
late-onset myopia in diabetic patients.  
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Authors who have investigated the effect of more acute changes in plasma 
glucose concentration have reported that an acute decrease in plasma 
glucose levels causes a (transient) hyperopic change (Keller 1973; Marmor 
1973; Gwinup and Villarreal 1976; Fledelius and Miyamoto 1987; Saito et al. 
1993; Willi 1996). Conversely other authors report the possibility of increasing 
hyperopia under hyperglycemic conditions (Huggert 1954; Rosen 1956; 
Vaughan and Asbury 1980). Rosen (1956) described a case-report where a 
hyperopic change was observed with increasing blood glucose levels, and 
Huggert (1954) studied the crystalline lens of 23 diabetic subjects. Ten 
subjects were myopic and 14 subjects were hyperopic (in one subject 
hyperopia was preceded by myopia, and was therefore counted twice). 
Vaughan and Asbury (1980) described both myopic and hyperopic refractive 
error changes in diabetes with changing blood glucose concentration.   
 
Thus both myopic and hyperopic shifts have been reported in diabetic patients 
and the underlying mechanism responsible remains to be established. Table 1 
summarises the results of various studies published in the scientific literature, 
describing acute refractive error changes with induced changes in blood 
glucose levels.  
 
Author Year No of 
subjects 
Key findings 
Huggert  1954 23 Myopia before and hyperopia after the 
onset of treatment 
Gwinup et al. 1976 10 Myopia after induced hyperglycaemia 
Fledelius  1987 72 Myopia and hyperopia (before and after 
the onset of treatment) 
Saito et al. 1993 5 Hyperopia after the onset of treatment 
Furushima et 
al. 
1999 7 Myopia after induced hyperglycaemia in 
non-diabetic subjects  
Steffes  1999 1 Myopia after induced hypoglycaemia 
Okamoto et al. 2000 14 Hyperopia after the onset of treatment 
Guisti  2003 20 Myopia after the onset of treatment 
Sonmez et al. 2005 18 Hyperopia after the onset of treatment 
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Table 1. Conflicting results presented in the literature comparing acute 
refractive changes in the eye to changing blood glucose levels. 
 
 
Different approaches have been adopted in the above studies, which may 
explain the lack of agreement in findings. It is important to define the words 
‘acute effect’, since investigators describe the refractive shifts at different time 
points after the commencement of the study. The majority of investigators 
have been interested in the response of the eye when elevated blood glucose 
levels were reduced to near normal values. This reduction could take several 
weeks to months to occur and might be considered a sub-acute response 
rather than a true acute response.  
 
Although our knowledge about the time required for glucose to enter the eye 
after blood plasma glucose concentration is increased is limited to animal 
models, it is thought that the latency is between 5 minutes (Cameron et al. 
2001) and 30 minutes (Chou and Lin 2000).  
 
Researchers (Caird et al. 1969; Saito et al. 1993) have examined the 
refractive shifts occurring after instigating (insulin) treatment for the first time. 
This may not reflect blood glucose changes as they occur on a day-to-day 
basis in treated diabetic patients. To investigate refractive error shifts in 
diabetic patients, the conditions require more ‘regular’ glucose fluctuations. 
The response of the eye to the body’s first experience with oral diabetes 
medications or injected insulin has not been thoroughly investigated. Insulin 
acts on cells throughout the body to stimulate the uptake, utilisation and 
storage of glucose. A sudden drop in extra-cellular glucose levels or an 
increase in intra-cellular glucose (as would occur in undiagnosed diabetes) 
might change the refractive index more significantly than when this change 
occurs on a hourly basis. 
 
It is possible that in diabetic patients, the membrane of the crystalline lens 
permits an influx of water into the lens when blood glucose levels fall.  During 
hypoglycaemia, the glucose concentration in the aqueous humour will 
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decrease (Figure 1).  As a consequence, the osmotic balance along the lens 
capsule or epithelium will increase the influx of water from the aqueous 
humour into the lens, and induce a refractive shift. This effect may be 
dramatic when treatment for diabetes mellitus is first initiated and may be 
different to the sorts of changes that occur when the diabetes is under control.  
 
 
 
Figure 1. Aqueous humour is produced by the ciliary body and secreted into 
the posterior chamber. It flows through the pupil into the anterior chamber, 
where it is drained by the trabecular meshwork and Schlemm’s canal 
(Reprinted from Forrester et al. 2002, with permission of Elsevier).     
 
 
Gwinup and Villarreal (1975) investigated the effects of chronic and acute 
changes in blood glucose levels on refractive error. In a group of ten subjects 
with diabetes they demonstrated that a decrease in blood glucose 
concentration of 100mg/dl (5.6mM/l) altered the refractive error by about 
0.50D over a period of few weeks. Furthermore, they demonstrated an acute 
change in refraction with changing blood glucose concentration in six out of 
ten of the diabetic subjects (Figure 2). In all six patients, the refraction 
became more myopic in both eyes within 15 minutes after an injection of 
glucose. The authors suggested that the accumulation of by-products of 
glucose metabolism within the lens, followed by the accumulation of water, 
had caused the lens to swell resulting in myopia (Gwinup and Villarreal 1976). 
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The initial blood glucose concentration in all 6 subjects was below 150mg/dl 
(8.4mM/l), but no measurements of blood glucose concentration were taken 
afterwards.   
 
Two of the diabetic subjects were aphakic and both aphakic subjects became 
more hypermetropic (rather than more myopic) after blood glucose 
concentration increased. These data also appear to suggest that the cause of 
the myopic refractive shift in the phakic subjects was likely to be due to the 
crystalline lens. The data from the aphakic subjects suggest that the cornea 
and the posterior lens capsule also appear to have an influence on refractive 
error fluctuations. However, since the refractive change was opposite in sign 
in the phakic versus the aphakic eyes, the anterior lens capsule, subcapsular 
epithelium and lens fibres may act to reverse any change induced by the 
cornea or by the lens capsule. Additionally, the data support the theory that 
the latency of refractive changes after blood glucose change is small.  
 
Figure 2. Changes in refraction of the eyes of aphakic diabetic subjects (n=4) 
and diabetic with intact lenses (n=12) following induced hyperglycemia (mean 
± SD) (Adapted from Gwinup and Villarreal 1976).   
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Steffes (1999) obtained similar results to those of Gwinup and Villarreal 
(1976). In a fasting Type I diabetic patient with a blood glucose concentration 
of about 95mg/dl (5.3mM/l), the administration of insulin caused the blood 
glucose concentration to reduce to about 50mg/dl (2.8mM/l) (Figure 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Comparison of (A) finger prick measurements of whole blood 
glucose taken with two different systems (circles and squares); and (B) 
measured refractive error during induced hypoglycemia (Adapted from Steffes 
1999). 
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Upon administration of dextrose (glucose), the patient’s blood glucose 
increased to about 5mM/l with system 1 and >8.0mM/l with system 2. 
Concurrent measurements of refractive error were made, and the changes in 
refractive error were closely tracked those of the blood glucose concentration. 
To the best of our knowledge, this is the only in vivo evidence in the literature 
of refractive error changes due to induced hypoglycaemia. The results of this 
study concur with Gwinup and Villarreal’s finding that the latency is short. 
 
A novel approach to the question of whether myopic or hypermetropic 
changes are caused by hyperglycemia was reported by Furushima et al. 
(Furushima et al. 1999). Somatostatin, which is known to suppress insulin 
secretion, was administered to a group of seven non-diabetic volunteers 
(mean age 23 years), with normal vision. Together with a glucose-load, the 
somatostatin induced hyperglycemia in all subjects. A statistically significant 
average change of –1.93±0.39 D in refractive error was observed 150 minutes 
after the glucose load despite the instillation of cycloplegic eye drops 
(p<0.01).  The subjects’ refractive error changed concurrently with their blood 
glucose level, which increased from 3.9±0.6mM/l to 15.6±2.3mM/l. The time 
taken to reach the maximum refractive power was the same as the time taken 
to reach the maximum blood glucose level. Ultrasound measurements 
showed significant changes in the dimensions of both the anterior chamber 
depth which became shorter, and the crystalline lens, which became thicker. 
The axial length of the eye remained unchanged. 
 
Aetiology of refractive error shifts in diabetes 
Thus there is still some uncertainty about how refractive error in humans is 
influenced by acute and chronic changes in blood glucose concentration.  
 
Both hypermetropic and myopic refractive shifts could occur from 
morphological changes in the cornea, crystalline lens, axial length or retinal 
thickness. The last two possibilities have been investigated previously, and no 
change in either axial length or retinal thickness was found with changing 
blood glucose concentration in 28 eyes (Okamoto et al. 2000).  
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Myopia 
A myopic shift with decreasing blood glucose concentration in diabetes could 
be explained by the accumulation of metabolites such as sorbitol. The 
intracellular glucose levels in the crystalline lens are not regulated by insulin, 
and therefore the concentration of glucose within the lens increases with 
increasing blood glucose concentration (Olansky 2004).  
 
Aldose reductase is an enzyme that converts any excess of intracellular 
glucose into sorbitol, which can then be further metabolised into fructose. Cell 
membranes are relatively impermeable to sorbitol allowing this compound to 
accumulate within the lens. This is paralleled by an influx of water from the 
aqueous humour, producing lenticular swelling (Gabbay 1973). This leads to 
an increase of lens curvature and induced myopia. 
 
Hyperopia 
A decrease in blood glucose concentration in the aqueous humour could also 
cause a transient difference in osmotic pressure between the aqueous 
humour, crystalline lens and vitreous body. As a result, a decrease in 
refractive index might develop in the lens, leading to a hyperopic shift. A 
decrease in lenticular refractive index from 1.42 to 1.40 has been shown to 
produce a hyperopic change of 3.20D (Planten 1981). Therefore, small 
changes in refractive index could produce significant changes in refractive 
power as stated above. 
 
Alternative theories have evolved from animal studies, when the response of 
the lens to changing glucose levels has been investigated (Jacob and Duncan 
1982). The crystalline lens was placed in solutions with different glucose 
concentrations, causing a hyper-osmotic and norm-osmotic shock. A hyper-
osmotic (or hypertonic) situation is created when the solution has a higher 
glucose concentration than the crystalline lens. The initial response in a frog 
lens to hyper-osmotic shock was a decrease in lens volume. A second 
response was gradual lens swelling, due to the net entry of glucose and water 
during high aqueous humour glucose levels. On return to norm-osmosis 
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(when the solution has an almost equal glucose concentration to the lens), the 
already swollen lens experienced hypo-osmotic shock and swelled still further 
with increased K+ permeability. This increase in K+ efflux (outward flow) is 
presumably used by cells to increase their volume in response to osmotic 
stress (Beebe et al. 1990). 
 
 
Author Mean change in 
blood glucose 
concentration 
(mM/l) 
Mean 
change in 
refractive 
error (D) 
Comments 
Gwinup and 
Villareal. 
+ 8.4 -0.50 None 
Furushima et al. + 11.2 -2.00 Cycloplegic refraction, 
insulin suppression, 
non-DM subjects 
Steffes - 2.8 -0.25 One subject 
Table 2. Results from three studies showing refractive error changes after 
induced hypo- or hyperglycemia. 
 
Table 2 summarises the results of the three human studies described above. 
It is perhaps surprising that cycloplegic refraction results in such a large 
refractive change. However, insulin secretion was completely suppressed in 
these subjects, resulting in very high blood glucose levels. Glucose would 
have been building up into the aqueous humour and extra-cellular space of 
the cornea and crystalline lens. As a result, the refractive index of the 
aqueous humour would be increased significantly causing a large refractive 
change.  
 
Implications for the optometrist 
Hyperglycemia often goes unnoticed by diabetic patients, whereas there may 
be several undesirable symptoms associated with acute hypoglycemia. A 
rapid decline in blood glucose concentration is associated with sweating, 
trembling, anxiety, weakness, hunger, nausea and vomiting. However, 
prolonged hypoglycemia can include more severe symptoms like visual 
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disturbances, restlessness, irritability, inability to concentrate, mental 
confusion, and personality changes among others (National Diabetes 
Information Clearinghouse 2003). Thus diabetic patients may take immediate 
action to correct for hypoglycaemia (usually with an intake of glucose), and 
any associated refractive error shifts may therefore be avoided.  
Consequently, the response of the crystalline lens to untreated 
hyperglycaemia may be of more immediate concern to the optometrist 
involved in carrying out eye examinations on diabetic patients.   
 
Thus, refractive error change can be influenced by fluctuating blood glucose 
concentration. Therefore it seems appropriate to enquire about blood glucose 
concentration when carrying out eye examinations on diabetic patients. If 
blood glucose concentration is uncharacteristically high or low at the time of 
refraction, then it may be wise to repeat the refraction prior to prescribing, as 
well as advising patients about the possible implications for diabetic 
retinopathy and other complications associated with the disease. 
 
In hyperglycemia, glucose can accumulate in the lens causing an increase in 
curvature and a shift towards myopia (Mantyjarvi 1988). However, hyperopic 
changes have also been shown to occur during hyperglycemia and this is 
thought to be due to a decrease in refractive index in the crystalline lens. If the 
geometric effect dominates (swelling of the lens altering lens curvature), the 
refraction will shift towards myopia.  If the refractive effect dominates, the 
refraction will shift towards hypermetropia. 
 
 
CONCLUSIONS 
 
The underlying mechanism governing the relationship between plasma 
glucose concentration and refractive error is not fully understood. There is no 
clear answer as to whether the refractive changes seen are due simply to 
changes in refractive index of the cornea, aqueous humour or lens or whether 
swelling of the lens occurs causing changes to the its curvature, position or 
size. It is possible that both the refractive index and surface curvature change, 
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in which case either a myopic or hyperopic response may occur, depending 
on the individual’s physiology. However, from a clinical point of view, 
fluctuating blood glucose concentration has an influence on short-term 
changes in refraction, and these changes may be large enough to measure. 
In the majority of cases, people with diabetes appear to become more myopic 
as their blood glucose concentration increases, but a significant minority 
become more hypermetropic. Where acute changes have been reported in 
the literature, the latency of these changes appears to be short, being of the 
order of a few minutes. This implies that a hypo- or hyperglycemic state could 
influence refractive findings during the eye-examination. When taking a 
diabetic patient’s history, it seems appropriate to enquire about the most 
recent blood glucose concentration, or even suggest taking a finger stick test 
before the eye-examination. It should be borne in mind that (consistently) high 
blood glucose readings could induce transient myopia. 
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